OrphAI Therapeutics

📍 Guilford, United States🗓 Founded 2013👥 13 employees💰 Last funded Aug 2021
Biotechnology Research🌐 orphai-therapeutics.com
Website LinkedIn
At OrphAI Therapeutics, we are focused on identifying and developing therapeutics for rare orphan conditions. We accelerate the development process by using a variety of methods to identify and acquire promising pipeline assets - including data mining, deep learning, and in-licensing. Our current clinical stage drug candidates target several orphan disorders including pulmonary sarcoidosis, bronchiolitis obliterans post lung transplant and amyotrophic lateral sclerosis.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
India
1
Frequently asked questions
Who invested in OrphAI Therapeutics?
OrphAI Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did OrphAI Therapeutics last raise funding?
The most recent investment in OrphAI Therapeutics recorded on gritt.io was in August 2021.
When was OrphAI Therapeutics founded?
OrphAI Therapeutics was founded in 2013.
What industry is OrphAI Therapeutics in?
OrphAI Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OrphAI Therapeutics based?
OrphAI Therapeutics is headquartered in Guilford, United States.